Cboe valuation walkthrough: the index-options machine is priced, Data Vantage durability is the new proof

Cboe's open-outcry floor still matters as a symbol of what the valuation is really buying: a durable derivatives franchise, not a one-quarter volatility spike.

Cboe is no longer being priced like a simple "VIX goes up, exchange makes more money" story. With CBOE.US at $287.71 on 2026-04-02, the company carries an equity value of roughly $30.1 billion using its year-end diluted share count.[1][3] That puts the stock at about 27.0x FY2025 adjusted diluted EPS of $10.67.[1][2][3] The premium is visible. Priced is that Cboe owns one of the best proprietary index-options tollbooths in global market structure. New is that 2026 has to prove the multiple can still stand when the story leans less on a spectacular trading year and more on mix quality, Data Vantage durability, and disciplined expense control.[2][3][4]

Image context: the cover uses a real photograph of Cboe's trading floor because this article is about an actual exchange franchise, actual traders, and an actual derivatives venue rather than an abstract finance graphic.[6]

Priced vs new

The market has already paid up for the obvious strengths. FY2025 revenues less cost of revenues reached $2.429 billion, adjusted operating margin reached 65.6%, and adjusted diluted EPS reached $10.67.[2][3] The balance sheet also gives Cboe room to keep acting like a compounder rather than a stretched cyclical: the company ended 2025 with $2.216 billion of cash and cash equivalents against $1.443 billion of long-term debt, while still holding $614.5 million of remaining repurchase authorization.[3]

What is newly worth isolating is the mix. Cboe's 2025 result was excellent, but not all of that excellence has the same persistence. Some of it came from a year in which derivatives volumes were unusually strong across the complex. Some of it came from business lines that behave more like recurring infrastructure. The valuation question in 2026 is about which layer deserves the premium.

Why the premium exists

1. Proprietary index options are still the core economic engine

The most defensible reason Cboe trades at a premium is that it owns products competitors cannot simply replicate. In 2025, derivatives markets generated $1.341 billion of revenues less cost of revenues, or a little over half of company net revenue, and management said the year-over-year gain was driven in part by a 21% increase in index-options ADV and a 24% increase in multi-listed options ADV.[3] That matters because proprietary index products do not behave like a commodity matching engine. They carry brand, licensing, habit, and workflow advantages.

February 2026 volume data show that the franchise is still deepening rather than merely holding ground. Cboe reported a record 6.0 million contracts of proprietary index-options ADV in the month, including a record 4.8 million contracts of SPX options ADV and a record 3.0 million contracts of SPX 0DTE ADV, equal to 63% of all SPX trading.[4] That is the cleanest sign that the franchise is not waiting for a volatility panic to stay relevant. It is becoming more embedded in everyday risk-transfer behavior.

2. Data Vantage is what keeps the story from collapsing into pure trading beta

If proprietary options explain why Cboe deserves a premium, Data Vantage explains why the premium does not have to vanish every time volumes cool. In 2025, Data Vantage produced $635.5 million of revenue and $622.9 million of revenues less cost of revenues.[2][3] Management's 2026 guide calls for Data Vantage organic net revenue growth in the mid to high single-digit range even as company-wide organic net revenue growth is only guided to the mid single-digit range.[2]

That spread is important. It means the more recurring, access-and-data-heavy part of the business is still expected to grow faster than the group. For valuation, that changes the character of the earnings stream. Investors are not just underwriting one more year of busy options markets. They are underwriting a company whose higher-quality non-transaction layer keeps getting thicker.

3. The stock only works cleanly if mix stays favorable while expenses stay disciplined

This is where the burden of proof moves in 2026. Management introduced adjusted operating expense guidance of $864 million to $879 million for the year.[2] That is not a company telling investors to pay any price for growth. It is a company telling them that margin quality still matters.

At roughly 27x trailing adjusted EPS, the stock does not need a collapse in trading volumes to feel expensive. It only needs evidence that the best 2025 ingredients are softening at the same time: less-helpful SPX mix, slower Data Vantage growth, or expense creep that eats into the franchise quality investors are paying for.[1][2][3][4]

Numeric anchors

$287.71 share price on 2026-04-02, implying equity value near $30.1 billion using 104,647,739 diluted shares outstanding at year-end 2025.[1][3]
FY2025 adjusted diluted EPS of $10.67, equal to about 27.0x trailing adjusted earnings at the latest price.[1][2][3]
FY2025 revenues less cost of revenues of $2.429 billion and adjusted operating margin of 65.6%.[2][3]
Year-end 2025 balance-sheet position of $2.216 billion cash against $1.443 billion long-term debt, plus $614.5 million of remaining repurchase authorization.[3]
FY2025 Data Vantage revenue of $635.5 million and revenues less cost of revenues of $622.9 million.[2][3]
February 2026 record proprietary index-options ADV of 6.0 million contracts, including 4.8 million SPX ADV and 3.0 million SPX 0DTE ADV, with 0DTE at 63% of SPX activity.[4]

Strongest counterweight

The strongest pushback is that the stock deserves to stay rich. Cboe has a rare combination: proprietary listed derivatives, strong incremental margins, a balance sheet that is still in net-cash territory, and a recurring data-and-access franchise that keeps widening.[2][3][4] If SPX and 0DTE adoption stay structurally high while Data Vantage keeps compounding, then a high-20s earnings multiple may read less like excess and more like the normal price of a scarce market-structure asset.

Falsifier

This framework gets too cautious if the next few quarters show that Cboe can hold mid-to-high-single-digit Data Vantage growth, keep proprietary index-option engagement near current levels, and stay inside the $864 million to $879 million adjusted expense guide even with calmer volatility conditions.[2][4][5] In that case, the market would be right to keep treating the company as a durable mix-improvement story rather than a stock that merely had a great 2025.

Watchlist

2026-05-01 first-quarter earnings release: this is the next hard read on whether Data Vantage growth, organic net revenue, and expense discipline are keeping the premium multiple intact.[5]
December 2026 targeted launch window for near 24x5 U.S. equities trading, pending SEC approval: this does not change the 2026 earnings story immediately, but it matters for how much optionality investors should attach to Cboe's broader market-structure platform.[7]

Takeaway

Cboe at roughly 27x trailing adjusted EPS is already priced as a high-quality exchange operator with scarce assets.[1][2][3] That judgment has real support: a 65.6% adjusted operating margin, a still-clean balance sheet, and a proprietary index-options franchise that keeps setting records instead of fading after one busy year.[2][3][4] The next proof is narrower. Investors no longer need evidence that Cboe can monetize volatility. They need evidence that Data Vantage and product mix can keep the stock expensive even when the tape is less dramatic.

cronfeed.work